Podcast: Switching to Long-acting ART
Audio on Switching to Long-Acting ART

Released: July 07, 2021

Expiration: July 06, 2022

Daniel R. Kuritzkes
Daniel R. Kuritzkes, 医学博士

Activity

Progress
1
Course Completed

In this episode, Daniel J. Kuritzkes, MD, reviews key clinical trial data and gives practical insights such as how to initiate a patient on long-acting therapy, recommended dosing regimens, and factors that may increase the risk of treatment failure. The overview will include analyses of:

  • ATLAS and FLAIR studies of long-acting injectable CAB + RPV
  • ATLAS 2M dosing study
  • FDA approval and DHHS statement on use of long-acting injectable ART
  • Studies on whether an oral lead-in is needed

Presenter:

Daniel R. Kuritzkes, MD
Chief, Division of Infectious Diseases
Brigham and Women’s Hospital
Harriet Ryan Albee Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Follow along with the slides at:
https://bit.ly/3hNfHII